EpiBiome Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $7M

EpiBiome General Information

Description

Developer of therapies designed to combat infectious diseases in humans and in agriculture without the use of antibiotics. The company's therapies utilize an integrated approach to combat infectious diseases in agriculture and human health using novel sequencing and bioinformatic processes and also identify pathogenic bacteria and microbiome changes that may contribute to disease development, enabling patients to recover from diseases.

Contact Information

Website
www.epibiome.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 201 Gateway, Boulevard
  • 2nd Floor
  • South San Francisco, CA 94080
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Locus Biosciences
Vertical(s)
AgTech, Supply Chain Tech, HealthTech, Life Sciences
Corporate Office
  • 201 Gateway, Boulevard
  • 2nd Floor
  • South San Francisco, CA 94080
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EpiBiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 17-Jul-2018 $7M 00.000 000 Completed Startup
10. Accelerator/Incubator 00.000 Completed Startup
9. Early Stage VC (Series B) 20-Jul-2016 00.000 Completed Startup
8. Accelerator/Incubator 20-Jul-2016 00.000 Completed Startup
7. Debt - General 23-Jun-2016 000 00.000 Completed Startup
6. Early Stage VC (Series A) 04-Feb-2016 00.00 00.000 000.00 Completed Startup
5. Grant 12-Nov-2015 00000 00000 Completed Startup
4. Angel (individual) 00000 Completed Startup
3. Accelerator/Incubator 03-Mar-2015 $120K Completed Startup
2. Accelerator/Incubator 01-Jan-2015 $120K Completed Startup
To view EpiBiome’s complete valuation and funding history, request access »

EpiBiome Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view EpiBiome’s complete cap table history, request access »

EpiBiome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapies designed to combat infectious diseases in humans and in agriculture without the use of antibiotic
Drug Discovery
South San Francisco, CA
14 As of 2016
00.000
000 0000-00-00
000000&0 00.000

00000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labor
0000 000000000
Woburn, MA
00 As of 0000
00000
0000000000 0 00000

000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
0000 000000000
Cambridge, MA
000 As of 0000
00000
0000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EpiBiome Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Axial Therapeutics Venture Capital-Backed Woburn, MA 00 00000 0000000000 0 00000
Vedanta Biosciences Venture Capital-Backed Cambridge, MA 000 00000 0000000000 00000
Theriva Biologics Corporation Rockville, MD 00 000.00 000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

EpiBiome Patents

  • 3

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

EpiBiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2988579-A1 Compositions and methods for increasing the susceptibility of bacteria to antibiotics Inactive 21-Apr-2015 0000000000
AU-2016250606-A1 Compositions and methods for increasing the susceptibility of bacteria to antibiotics Inactive 21-Apr-2015 0000000000
EP-3285587-A1 Compositions and methods for increasing the susceptibility of bacteria to antibiotics Inactive 21-Apr-2015 A61K35/747

EpiBiome Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EpiBiome Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority 000 0000 000000 0
BayBio FAST Accelerator/Incubator 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
BlackRock Asset Manager Minority 000 0000 000000 0
CRCM Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

EpiBiome FAQs

  • When was EpiBiome founded?

    EpiBiome was founded in 2013.

  • Who is the founder of EpiBiome?

    Aeron Hammack Ph.D, Christina Tsai Ph.D, Nicholas Conley Ph.D, and Hsiao-Lu Lee Ph.D are the founders of EpiBiome.

  • Where is EpiBiome headquartered?

    EpiBiome is headquartered in South San Francisco, CA.

  • What is the size of EpiBiome?

    EpiBiome has 14 total employees.

  • What industry is EpiBiome in?

    EpiBiome’s primary industry is Drug Discovery.

  • Is EpiBiome a private or public company?

    EpiBiome is a Private company.

  • What is the current valuation of EpiBiome?

    The current valuation of EpiBiome is 000.

  • What is EpiBiome’s current revenue?

    The current revenue for EpiBiome is 00000.

  • How much funding has EpiBiome raised over time?

    EpiBiome has raised $7.22M.

  • Who are EpiBiome’s investors?

    Alexandria Venture Investments, BayBio FAST, Bill & Melinda Gates Foundation, BlackRock, and CRCM Ventures are 5 of 16 investors who have invested in EpiBiome.

  • Who are EpiBiome’s competitors?

    Axial Therapeutics, Vedanta Biosciences, and Theriva Biologics are competitors of EpiBiome.

  • When was EpiBiome acquired?

    EpiBiome was acquired on 17-Jul-2018.

  • Who acquired EpiBiome?

    EpiBiome was acquired by Locus Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »